2018
DOI: 10.1111/joic.12553
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of patient and staff exposure with state of the art X‐ray technology in cardiac catheterization: A randomized controlled trial

Abstract: The new x-ray and image processing technology, significantly reduces patient dose in coronary angiographies, and PCIs by 67%. In general, scatter dose was also reduced, yet for some dosimeters the reduction was limited and not statistically significant. This study clearly indicates that the scatter behavior is highly dependent on C-arm rotation, operator movement and height, dosimeter position, beam filtration, clinical procedure type and system geometry.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
(1 citation statement)
references
References 33 publications
1
0
0
Order By: Relevance
“…Therefore, the RAD-IR radiation doses and DRLs should no longer be considered the gold standard for this procedure, considering the changes in x-ray technology. This is supported by similar reductions in patient radiation dose in other recent studies of interventional procedures using new fluoroscopic technology, including uterine fibroid embolization (PKA reduction 77%) (Thomaere et al 2018), TACE for hepatocellular carcinoma (PKA reduction 66%) (Schernthaner et al 2015), bronchial artery embolization (PKA reduction 59%) (Spink et al 2017) and cardiac catherization/angioplasty (PKA reduction 67%) (Buytaert et al 2018).…”
Section: Discussionsupporting
confidence: 61%
“…Therefore, the RAD-IR radiation doses and DRLs should no longer be considered the gold standard for this procedure, considering the changes in x-ray technology. This is supported by similar reductions in patient radiation dose in other recent studies of interventional procedures using new fluoroscopic technology, including uterine fibroid embolization (PKA reduction 77%) (Thomaere et al 2018), TACE for hepatocellular carcinoma (PKA reduction 66%) (Schernthaner et al 2015), bronchial artery embolization (PKA reduction 59%) (Spink et al 2017) and cardiac catherization/angioplasty (PKA reduction 67%) (Buytaert et al 2018).…”
Section: Discussionsupporting
confidence: 61%